Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Fang, C.B., D.X. Zhou, S.X. Zhan, Y. He, Z. Lin, C. Huang, and J. Li. 2013. Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats. PLoS ONE 8 (4): e62071. https://doi.org/10.1371/journal.pone.0062071.
2. Chen, N., S. Chen, Z. Zhang, X. Cui, L. Wu, K. Guo, et al. 2021. Overexpressing Kallistatin aggravates experimental autoimmune uveitis through Promoting Th17 differentiation. Frontiers in Immunology 12: 756423. https://doi.org/10.3389/fimmu.2021.756423.
3. Glover, K., D. Mishra, and T.R.R. Singh. 2021. Epidemiology of ocular manifestations in autoimmune disease. Frontiers in Immunology 12: 744396. https://doi.org/10.3389/fimmu.2021.744396.
4. Gamalero, L., G. Simonini, G. Ferrara, S. Polizzi, T. Giani, and R. Cimaz. 2019. Evidence-based treatment for uveitis. The Israel Medical Association Journal 21 (7): 475–479.
5. Kasper, M., K. Walscheid, B. Laffer, D. Bauer, M. Busch, L. Wildschütz, et al. 2018. The phenotype of monocytes in anterior uveitis depends on the HLA-B27 status. Frontiers in Immunology 9: 1773. https://doi.org/10.3389/fimmu.2018.01773.